ABC has ordered “Dr. Odyssey,” which will star Joshua Jackson. The straight-to-series drama comes from 20th Television in association with Ryan Murphy Television.
Jackson is set to star in the lead role and executive produce the project. The actor most recently appeared in “Dr. Death” and “Fatal Attraction,” and was recently announced to star in Sony Pictures’ feature film, “Karate Kid.” The new series’ concept and logline are not being shared at this time, but the show is expected to debut in the fall.
Murphy, Jon Robin Baitz (“Feud: Capote vs. The Swans”) and Joe Baken (“I Am Michael”) will serve as the writers and executive producers of the series. Additionally, Paris Barclay (“Dahmer — Monster: The Jeffrey Dahmer Story”) will direct and executive produce, while Eric Paquette, Alexis Martin Woodall, Eric Kovtun, Scott Robertson and Nissa Diederich will EP.
“Dr. Odyssey” will mark the second Ryan Murphy show to come to ABC. After its cancelation at Fox, “9-1-1” was picked up by ABC and recently premiered on the network. Its first episode in Season 7 garnered 8.85 million total viewers across ABC, Hulu and other digital platforms, according to Nielsen live-plus-three-day figures and internal streaming data. It also scored a 1.84 rating in the key broadcast demo among adults 18-49, marking the series’ highest rating in nearly two years.
Despite “9-1-1” moving to ABC, its spin-off, “9-1-1: Lone Star,” is still at Fox. Season 5 is planned to return in the fall of this year.
“Dr. Odyssey” is just one of several Murphy projects that are either scheduled to premiere in 2024 or are in development. On FX’s side, “Feud: Capote vs. The Swans” concluded in mid-March, and the second part of “American Horror Story: Delicate” is set to premiere on April 3. “American Sports Story” and “American Love Story” are also set to be released sometime in the future, though premiere dates are currently unknown. As for Netflix, the second season of “Monster,” titled “Monsters: The Lyle and Erik Menéndez Story,” is planned to be released in 2024.
